PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Up 1,271.7% in May

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totaling 51,769 shares, a growth of 1,271.7% from the April 30th total of 3,774 shares. Based on an average daily trading volume, of 347,170 shares, the days-to-cover ratio is presently 0.1 days.

PharmaTher Stock Performance

Shares of PHRRF stock traded down $0.00 on Wednesday, reaching $0.05. 62,500 shares of the company’s stock traded hands, compared to its average volume of 181,361. PharmaTher has a 12-month low of $0.04 and a 12-month high of $0.55. The business’s 50 day moving average price is $0.05 and its two-hundred day moving average price is $0.07.

About PharmaTher

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.